OTC · Medical - Diagnostics & Research

Eurofins Scientific SE (ERFSF) Stock

$81.74 +5.24% OTC: ERFSF Healthcare

Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, trackability, and cleanliness.

Valuation

MetricValue
Price$81.74
Market Cap$14.14B
P/E Ratio27.93
P/B Ratio3.52
P/S Ratio1.64
EPS (TTM)$2.93
52-Week High$86.20
52-Week Low$64.95
Dividend Yield1.03%

Financials & Margins

MetricValue
ROE11.62%
ROA4.32%
ROCE13.32%
Gross Margin16.38%
Operating Margin15.62%
Net Margin6.51%
Debt/Equity1.53
Current Ratio1.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.7B$6.7B$6.5B$7.0B$7.3B
Operating Profit$1.3B$783.0M$1.2B$726.0M$818.0M
Net Profit$783.0M$610.0M$310.0M$406.0M$475.0M
EPS$3.90$3.07$1.57$2.09$2.54
Op Margin18.8%11.7%19.0%10.4%11.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$9.3B$10.1B$10.9B$10.9B$11.0B
Total Liabilities$4.7B$5.2B$5.8B$5.5B$7.4B
Cash$515.0M$487.0M$1.2B$614.0M$791.0M
Borrowings$2.8B$3.3B$3.9B$3.6B$4.4B

Latest News

Eurofins Scientific: Director/PDMR Shareholding Business Wire · Jul 16, 2026 Eurofins Scientific SE: Weekly Report on Share Repurchases From 06th July to 10th July 2026 Business Wire · Jul 13, 2026 Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2026 Business Wire · Jul 13, 2026 Eurofins Scientific SE: Weekly report on share repurchases from 29th June to 03rd July 2026 Business Wire · Jul 6, 2026 Eurofins: Weekly Report on Share Repurchases From 22nd June to 26th June 2026 Business Wire · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.5B$1.1B$1.0B$1.3B$1.3B
Investing Cash Flow$-1.6B$-1.5B$-1.2B$-1.4B$-1.8B
Financing Cash Flow$-363.0M$-87.0M$282.0M$-634.0M$-1.2B
Net Cash Flow$-395.0M$-32.0M$738.0M$-608.0M$323.0M
Free Cash Flow$990.0M$476.0M$468.0M$791.0M$535.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.70
EV / EBITDA15.08
FCF Yield3.37%
Quick Ratio1.03
Interest Coverage6.86
Return 1Y8.51%
Return 3Y14.09%
Return 5Y-34.02%

Ownership

Insiders Held36.50%
Institutions Held34.61%
Institutions Float Held54.51%
Institutional HolderSharesReport Date
Gardner Russo & Quinn, LLC3,096,4042026-03-31
Pacer Advisors, Inc.5272026-03-31
Lountzis Asset Management, LLC7,4332026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDUUYBangkok Dusit Medical Services Public Company Limited $23.41 +0.00% 20.00 $9.30B 6.83%
BIOVFSwedish Orphan Biovitrum AB (publ) $49.03 +0.00% 173.58 $16.96B 0.00%
BMXMFbioMérieux S.A. $80.31 +0.00% 20.73 $9.48B 1.41%
CHEOFCochlear Limited $78.94 -6.84% 21.25 $5.16B 3.83%
CHEOYCochlear Limited $39.03 -6.02% 21.25 $5.11B 3.89%

About Eurofins Scientific SE

Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, trackability, and cleanliness. Its offerings span numerous sectors. These include agro-science, encompassing biological evaluations, consumer, human, and environmental safety assessments, product chemical analysis, regulatory guidance, and seed services. The company also handles general agro testing. Its assurance division provides product inspections, audits, certifications, training, and advisory services for items across food, consumer goods, healthcare, and cosmetics industries. Other specialized areas are biopharma and clinical diagnostics. Furthermore, Eurofins conducts comprehensive consumer product testing, covering compliance, audits, examinations, certifications, inspections, training programs, and digital media and cybersecurity solutions for a diverse range of sectors. It also specializes in cosmetics and personal care product analysis, and environmental testing for substances like water, air, soil, waste, and other materials. Food and feed testing is another key segment, addressing concerns such as allergens, GMOs, grain quality, meat composition, nanomaterials, pesticides, and residual DNA. The company's extensive food-related portfolio also includes audit and certification services, authenticity verification, carbohydrate analysis, consulting, detection of dioxins and persistent organic pollutants (POPs), food irradiation checks, labeling compliance, legal guidance, heavy metal screening, identity preservation, mealtime analysis, molecular and microbiology testing, mycotoxin detection, nutritional profiling, organic contaminant analysis, packaging and migration studies, radioactivity testing, rapid testing methods, sensory and consumer research, various training initiatives, veterinary drug residue screening, and vitamin content analysis. Beyond these, Eurofins offers expertise in forensic science, genomics, maritime applications, materials and engineering, REACH compliance, and advanced technologies. The company maintains a significant global presence, operating roughly 900 laboratories across 54 nations. Established in 1987, its main office is situated in Luxembourg City, Luxembourg.

Eurofins Scientific SE is headquartered in LU.

Eurofins Scientific SE (ERFSF) stock trades at $81.74 with a market capitalization of $14.14B. The stock is valued at a price-to-earnings (P/E) ratio of 27.93, price-to-book of 3.52, price-to-sales of 1.64. Over the past 52 weeks the stock has ranged between $64.95 and $86.20, and currently trades 5.2% below its 52-week high. It pays a dividend yielding 1.03%.

On profitability, Eurofins Scientific SE generates a return on equity (ROE) of 11.62%, return on capital employed of 13.32%, an operating margin of 15.62%, a net profit margin of 6.51%.

Official website: www.eurofins.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides